1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Danielle Wallace: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP Mosunetuzumab, ClonoSEQ - Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | Recruiting | Danielle Wallace | 40 | 2025-09-04 | 2025-10-20 |
Lymphoma, Large B-Cell, Diffuse (1) · Neoplasm, Residual (1)
United States (1)